Johnson & Johnson Puts 15-Year Meritless Talc Litigation To Rest
Johnson & Johnson reached a $5.5 billion agreement to resolve remaining federal and state talc litigation over ovarian cancer claims.
Johnson & Johnson settled a long legal fight about talc products for $5.5 billion, meaning the company can finally move past this problem and focus on other things. When a big company resolves a huge lawsuit, watch to see if they can now operate more smoothly and investors feel calmer about their future.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.